EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An adolescent case of xeroderma pigmentosum variant confirmed by the onset of sun exposure‐related skin cancer during Crohn's disease treatment

Aoi Terada, Masahiro Aoshima, Hideaki Tanizaki, Yuka Nakazawa, Tomoo Ogi, Yoshiki Tokura, Shinichi Moriwaki

Journal of Cutaneous Immunology and Allergy · 2018

DOI: 10.1002/cia2.12011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cutaneous Immunology and Allergy, 2018. Verfasst von Aoi Terada und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The patient was a 16‐year‐old boy who was diagnosed with Crohn's disease at 13 years of age, who was treated with mesalazine, azathioprine, and infliximab. Concurrently, the patient developed small freckle‐like pigmented spots on sun‐exposed areas, which gradually increased in number. At 14 and 16 years of age, a blue‐gray macule and a nodule appeared on his face, respectively. A histopathological examination revealed that the macule had only postinflammatory pigmentation, while the nodule was basal cell carcinoma. The sensitivity to UV ‐killing by colony formation of the patient's cells was normal but was enhanced by caffeine treatment. In addition, a pathologic mutation in the POLH gene was identified and a diagnosis of xeroderma pigmentosum variant ( XP ‐V) was established. XP ‐V is a cutaneous type of XP that is commonly diagnosed from middle age after the induction of skin cancer on sun‐exposed areas. Our patient had a genetically sensitive background ( XP ‐V), and we considered that immunosuppressive agents for Crohn's disease may have enhanced the photocarcinogenesis at a young age. This finding implies that we should be careful about a skin cancer production and that protection from UV may be essential when pediatric patients with a genetic background of UV sensitivity take immunosuppressive agents.

Zitieren

APA

Terada, A., Aoshima, M., Tanizaki, H., Nakazawa, Y., Ogi, T., Tokura, Y., & Moriwaki, S. (2018). An adolescent case of xeroderma pigmentosum variant confirmed by the onset of sun exposure‐related skin cancer during Crohn's disease treatment. Journal of Cutaneous Immunology and Allergy. https://doi.org/10.1002/cia2.12011

Vancouver

Terada A, Aoshima M, Tanizaki H, Nakazawa Y, Ogi T, Tokura Y, et al. An adolescent case of xeroderma pigmentosum variant confirmed by the onset of sun exposure‐related skin cancer during Crohn's disease treatment. Journal of Cutaneous Immunology and Allergy. 2018. doi:10.1002/cia2.12011

BibTeX
@article{Terada2018,
  author = {Terada, Aoi and Aoshima, Masahiro and Tanizaki, Hideaki and Nakazawa, Yuka and Ogi, Tomoo and Tokura, Yoshiki and Moriwaki, Shinichi},
  title = {An adolescent case of xeroderma pigmentosum variant confirmed by the onset of sun exposure‐related skin cancer during Crohn's disease treatment},
  journal = {Journal of Cutaneous Immunology and Allergy},
  year = {2018},
  doi = {10.1002/cia2.12011}
}
Kostenlos starten →